Skip to main content
Year archive

DIMERIX LIMITED — 2023 filings

All 91 regulatory filings released by DIMERIX LIMITED (DXB) in 2023, sourced directly from the official regulator.

91 Filings
2023 Period
2023 filings (91)
Filing Released Lang
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-12-28 English
Notification regarding unquoted securities - DXB 6 pages 28.6KB
Regulatory Filings
2023-11-30 English
Initial Director's Interest Notice - MD 2 pages 270.1KB
Regulatory Filings
2023-11-30 English
Change of Director's Interest Notice - NW 3 pages 283.5KB
Regulatory Filings
2023-11-30 English
ACTION3 IND Approved in China 3 pages 298.7KB
Regulatory Filings
2023-11-27 English
AGM Presentation 17 pages 2.3MB
Regulatory Filings
2023-11-20 English
Results of Meeting 2 pages 306.3KB
Regulatory Filings
2023-11-20 English
Dimerix Announces the Appointment of Non-Executive Chairman 3 pages 349.4KB
Regulatory Filings
2023-11-19 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-11-13 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-11-07 English
Dimerix Receives Initial Upfront Payment from Advanz Pharma 3 pages 381.0KB
Regulatory Filings
2023-11-05 English
Change of Director's Interest Notices - NW 3 pages 282.3KB
Regulatory Filings
2023-11-05 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-11-02 English
Notification of cessation of securities - DXB 4 pages 23.9KB
Regulatory Filings
2023-10-30 English
Quarterly Appendix 4C and Activities Report 9 pages 681.5KB
Regulatory Filings
2023-10-29 English
Notification of cessation of securities - DXB 4 pages 24.0KB
Regulatory Filings
2023-10-24 English
Letter to Shareholders, Notice of AGM & Proxy Form 34 pages 1.1MB
Regulatory Filings
2023-10-23 English
Dimerix Appoints Chief Medical Officer 3 pages 342.2KB
Regulatory Filings
2023-10-22 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-10-19 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-10-16 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-10-15 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-10-08 English
Dimerix Announces License Agreement for EU, Canada, ANZ 5 pages 367.7KB
Regulatory Filings
2023-10-04 English
Investor Webinar and Presentation 14 pages 2.2MB
Regulatory Filings
2023-10-04 English
Trading Halt 2 pages 448.3KB
Regulatory Filings
2023-10-03 English
FDA Approves Qytovra Brand Name 4 pages 443.7KB
Regulatory Filings
2023-09-24 English
Notification of Date of 2023 AGM 1 page 308.0KB
Regulatory Filings
2023-09-24 English
Regulatory Approval received in Malaysia for ACTION3 Study 3 pages 437.9KB
Regulatory Filings
2023-09-21 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-09-18 English
Dimerix Receives $8.9M R&D Tax Incentive Rebate 3 pages 395.5KB
Regulatory Filings
2023-09-12 English
Preliminary Final Report 2 pages 320.3KB
Regulatory Filings
2023-08-29 English
Annual Report 78 pages 3.2MB
Regulatory Filings
2023-08-29 English
Appendix 4G and Corporate Governance Statement 27 pages 705.2KB
Regulatory Filings
2023-08-29 English
Application for quotation of securities - DXB 7 pages 30.2KB
Regulatory Filings
2023-08-27 English
Notification regarding unquoted securities - DXB 5 pages 26.4KB
Regulatory Filings
2023-08-27 English
Application for quotation of securities - DXB 7 pages 30.3KB
Regulatory Filings
2023-08-08 English
Notification regarding unquoted securities - DXB 5 pages 26.4KB
Regulatory Filings
2023-08-08 English
Successful Completion of 2nd DSMB Review of FSGS Trial 3 pages 388.7KB
Regulatory Filings
2023-08-07 English
Investor Presentation 26 pages 4.4MB
Regulatory Filings
2023-07-31 English
Quarterly Appendix 4C and Activities Report 9 pages 662.6KB
Regulatory Filings
2023-07-27 English
DMX-200 FSGS PH3 Kidney Trial Part 1 Outcome set for Q1 CY24 4 pages 416.9KB
Regulatory Filings
2023-07-23 English
Dimerix presentation at Bioshares Biotech Summit 19 pages 2.8MB
Regulatory Filings
2023-07-23 English
Approval received for Paediatric Investigation Plan from EMA 5 pages 358.2KB
Regulatory Filings
2023-07-04 English
Change of Director's Interest Notices - NW and SP 6 pages 326.6KB
Regulatory Filings
2023-07-03 English
Dimerix confirms Phase 3 study design appropriate for China 4 pages 387.4KB
Regulatory Filings
2023-07-02 English
Notification regarding unquoted securities - DXB 5 pages 26.4KB
Regulatory Filings
2023-06-28 English
Notification regarding unquoted securities - DXB 5 pages 26.2KB
Regulatory Filings
2023-06-28 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-06-28 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-06-28 English
Application for quotation of securities - DXB 6 pages 27.9KB
Regulatory Filings
2023-06-28 English
Application for quotation of securities - DXB 7 pages 30.3KB
Regulatory Filings
2023-06-28 English
Prospectus 38 pages 872.1KB
Regulatory Filings
2023-06-25 English
Results of Meeting 4 pages 437.8KB
Regulatory Filings
2023-06-19 English
Application for quotation of securities - DXB 6 pages 28.1KB
Regulatory Filings
2023-06-14 English
Change of Director's Interest Notices - NW and SP 6 pages 328.9KB
Regulatory Filings
2023-06-12 English
Dimerix to present at BIO International Convention 20 pages 3.7MB
Regulatory Filings
2023-06-05 English
Change in substantial holding 3 pages 144.2KB
Regulatory Filings
2023-06-05 English
Dimerix Announces Update on Successful Capital Raise 3 pages 321.6KB
Regulatory Filings
2023-06-04 English
Application for quotation of securities - DXB 7 pages 30.4KB
Regulatory Filings
2023-06-04 English
Notification regarding unquoted securities - DXB 5 pages 26.4KB
Regulatory Filings
2023-06-04 English
Top 20 Option Holders & Distribution Schedule 3 pages 90.2KB
Regulatory Filings
2023-06-04 English
Reminder of Closing Date for Non-Renounceable Rights Offer 5 pages 355.8KB
Regulatory Filings
2023-05-25 English
Notification regarding unquoted securities - DXB 7 pages 31.7KB
Regulatory Filings
2023-05-24 English
Application for quotation of securities - DXB 6 pages 27.7KB
Regulatory Filings
2023-05-24 English
Letter to Shareholders, Notice of Meeting & Proxy Form 44 pages 1.2MB
Regulatory Filings
2023-05-21 English
Despatch of Prospectus and Letter to Eligible Shareholders 6 pages 1.2MB
Regulatory Filings
2023-05-11 English
Letter to Nominees and Custodians 4 pages 346.7KB
Regulatory Filings
2023-05-11 English
Letter to Ineligible Foreign Shareholders 1 page 29
Regulatory Filings
2023-05-11 English
Entitlement offer and Convertible Note to raise $12 million 17 pages 466.3KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 6 pages 30.4KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 7 pages 34.6KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 6 pages 30.5KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 6 pages 30.0KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 10 pages 44.8KB
Regulatory Filings
2023-05-03 English
Proposed issue of securities - DXB 5 pages 27.3KB
Regulatory Filings
2023-05-03 English
Investor Presentation 32 pages 6.5MB
Regulatory Filings
2023-05-03 English
Reinstatement to Official Quotation 1 page 89.9KB
Regulatory Filings
2023-05-03 English
Rights Issue Prospectus 56 pages 1.2MB
Regulatory Filings
2023-05-03 English
Investor Webinar 2 pages 297.7KB
Regulatory Filings
2023-05-03 English
Voluntary Suspension 2 pages 446.6KB
Regulatory Filings
2023-05-02 English
Initial Director's Interest Notice - CS 2 pages 270.3KB
Regulatory Filings
2023-05-01 English
Trading Halt 2 pages 474.2KB
Regulatory Filings
2023-04-30 English
Dimerix Announces New Board Member 2 pages 292.1KB
Regulatory Filings
2023-04-30 English
Quarterly Appendix 4C and Activities Report 9 pages 512.5KB
Regulatory Filings
2023-04-27 English
Ceasing to be a substantial holder 1 page 181.6KB
Regulatory Filings
2023-04-20 English
FSGS Study, Partnering & Commercialisation Investor Briefing 13 pages 2.0MB
Regulatory Filings
2023-03-21 English
Half-Year Financial Report & Appendix 4D - 31 December 2022 24 pages 967.4KB
Regulatory Filings
2023-02-26 English
DXB to Receive $2.8m in Prepayment of R&D Tax Incentive 3 pages 346.7KB
Regulatory Filings
2023-02-16 English
Successful Completion of DSMB Review of Phase 3 FSGS Trial 4 pages 333.8KB
Regulatory Filings
2023-02-08 English
Quarterly Appendix 4C and Activities Report 9 pages 599.7KB
Regulatory Filings
2023-01-30 English
FDA Confirms Inclusion of Paediatrics in ACTION3 Study 3 pages 322.2KB
Regulatory Filings
2023-01-11 English